As Climate Change Tightens Grip, Tanzania Braces For More Cholera Outbreaks 24/10/2018 Kizito Makoye DAR ES SALAAM, Tanzania -- Salma Mahmoud sits under a Neem tree with her chin perched on her palms. She’s still moaning the death of her son Abdul, who died to cholera a year ago after guzzling suspected contaminated water. Continue reading -> Global Health Grand Challenges Meeting Ends On Hopeful Note 19/10/2018 Monika Ermert More dedicated to scientific research and much more “colourful” than the World Health Summit were descriptions for the 14th Global Grand Challenges Meeting 2018 that ended last night in Berlin and brought together some top researchers, policymakers and civil society. Like the WHS, the Grand Challenges Meeting focused on antimicrobial resistances and pandemic pathogens. But it also talked a little more on the issue of how better to incentivize R&D to fulfil SDG3, the UN Sustainable Development Goal on health, according to participants. Continue reading -> Immunisation Programmes In Africa Face Challenges 19/10/2018 Justus Wanzala NAIROBI, Kenya -- Countries in sub-Saharan Africa face myriad obstacles in ensuring their populations receive requisite vaccinations to combat diseases. Continue reading -> Antimicrobial Resistance At The World Investment Forum: UNCTAD, WHO Join Forces 16/10/2018 Catherine Saez The World Investment Forum 2018, a biennial event organised by the United Nations Conference on Trade and Development (UNCTAD), will hold a session on health this year jointly with the World Health Organization. The session will address the need for investment in the development of new antibiotics, hoping to raise interest among investors. Continue reading -> World Health Summit: 11 Groups Sign Collaboration; Civil Society Sees Lack Of NGOs 16/10/2018 Monika Ermert BERLIN -- Answering the call by German Chancellor Angela Merkel, Ghana's President Nana Addo Dankwa Akufo-Addo and Norway's Prime Minister Erna Solberg for a global action plan for pushing global health, heads of 11 major health organisations today signed “a commitment to find new ways of working together to accelerate progress towards achieving the United Nations’ Sustainable Development Goals” at the close of the World Health Summit in Berlin. Continue reading -> An Expert View: After The UN High-Level Meetings On TB, NCDs, What Happens Next? 16/10/2018 David Branigan The United Nations late last month sought to hold landmark high-level meetings on ending tuberculosis and fighting noncommunicable diseases like cancer and cardiovascular disease, with mixed results. Now a Swiss-based expert is looking at the outcomes and what comes next, and in a webinar talked about the political trade-offs resulting from the meetings, the need to push for an integrated agenda on Universal Health Coverage, and how the private sector should be engaged. Continue reading -> Novartis, GARDP Join Forces To Reduce Child Deaths From Antimicrobial Resistance 16/10/2018 David Branigan Novartis and the Global Antibiotic Research & Development Partnership (GARDP) have announced that they are “joining forces” to reduce child deaths from antimicrobial resistance (AMR) by accelerating “the development and availability of generic antibiotic treatments for children in low- and middle-income countries,” according to a GARDP press release. Continue reading -> World Health Summit Berlin: New Global Action Plan; Gates And Merkel To Open Global Challenges 15/10/2018 Monika Ermert BERLIN -- Ten years after establishing the Berlin World Health Summit, the M8 alliance of medical institutes around the globe sees some noticeable progress in political commitment to the health agenda. “Gifts” presented at the opening ceremony yesterday in the German capital include the announcement of German Health Minister Jens Spahn to establish a Hub for Global Health and step up its financial contributions to the World Health Organization (WHO) to 115 million euros over the next four years. The three-day summit also will receive a global action plan to catch up with the United Nations Sustainable Development Goal (SDG) 3 on health and well-being for all. Continue reading -> “The People’s Prescription”: New Report Calls For Value Creation Instead Of Value Extraction In Pharmaceutical R&D 15/10/2018 David Branigan A new report, “The People's Prescription: Re-imagining health innovation to deliver public value,” calls for restructuring research and development innovation systems to create, rather than extract, value. It also calls for long-term “mission-oriented” public investment, and a public return on this investment. Continue reading -> Investing In Tobacco Free Portfolios: An Interview With Bronwyn King 11/10/2018 William New BAD GASTEIN, Austria -- People and institutions around the world may be unknowingly contributing to “the world’s number one cause of preventable death, via their pension funds,” according to Tobacco Free Portfolios, a global group working to cut off investment in tobacco products. And policymakers have a role to play, says the group’s CEO, Bronwyn King. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Global Health Grand Challenges Meeting Ends On Hopeful Note 19/10/2018 Monika Ermert More dedicated to scientific research and much more “colourful” than the World Health Summit were descriptions for the 14th Global Grand Challenges Meeting 2018 that ended last night in Berlin and brought together some top researchers, policymakers and civil society. Like the WHS, the Grand Challenges Meeting focused on antimicrobial resistances and pandemic pathogens. But it also talked a little more on the issue of how better to incentivize R&D to fulfil SDG3, the UN Sustainable Development Goal on health, according to participants. Continue reading -> Immunisation Programmes In Africa Face Challenges 19/10/2018 Justus Wanzala NAIROBI, Kenya -- Countries in sub-Saharan Africa face myriad obstacles in ensuring their populations receive requisite vaccinations to combat diseases. Continue reading -> Antimicrobial Resistance At The World Investment Forum: UNCTAD, WHO Join Forces 16/10/2018 Catherine Saez The World Investment Forum 2018, a biennial event organised by the United Nations Conference on Trade and Development (UNCTAD), will hold a session on health this year jointly with the World Health Organization. The session will address the need for investment in the development of new antibiotics, hoping to raise interest among investors. Continue reading -> World Health Summit: 11 Groups Sign Collaboration; Civil Society Sees Lack Of NGOs 16/10/2018 Monika Ermert BERLIN -- Answering the call by German Chancellor Angela Merkel, Ghana's President Nana Addo Dankwa Akufo-Addo and Norway's Prime Minister Erna Solberg for a global action plan for pushing global health, heads of 11 major health organisations today signed “a commitment to find new ways of working together to accelerate progress towards achieving the United Nations’ Sustainable Development Goals” at the close of the World Health Summit in Berlin. Continue reading -> An Expert View: After The UN High-Level Meetings On TB, NCDs, What Happens Next? 16/10/2018 David Branigan The United Nations late last month sought to hold landmark high-level meetings on ending tuberculosis and fighting noncommunicable diseases like cancer and cardiovascular disease, with mixed results. Now a Swiss-based expert is looking at the outcomes and what comes next, and in a webinar talked about the political trade-offs resulting from the meetings, the need to push for an integrated agenda on Universal Health Coverage, and how the private sector should be engaged. Continue reading -> Novartis, GARDP Join Forces To Reduce Child Deaths From Antimicrobial Resistance 16/10/2018 David Branigan Novartis and the Global Antibiotic Research & Development Partnership (GARDP) have announced that they are “joining forces” to reduce child deaths from antimicrobial resistance (AMR) by accelerating “the development and availability of generic antibiotic treatments for children in low- and middle-income countries,” according to a GARDP press release. Continue reading -> World Health Summit Berlin: New Global Action Plan; Gates And Merkel To Open Global Challenges 15/10/2018 Monika Ermert BERLIN -- Ten years after establishing the Berlin World Health Summit, the M8 alliance of medical institutes around the globe sees some noticeable progress in political commitment to the health agenda. “Gifts” presented at the opening ceremony yesterday in the German capital include the announcement of German Health Minister Jens Spahn to establish a Hub for Global Health and step up its financial contributions to the World Health Organization (WHO) to 115 million euros over the next four years. The three-day summit also will receive a global action plan to catch up with the United Nations Sustainable Development Goal (SDG) 3 on health and well-being for all. Continue reading -> “The People’s Prescription”: New Report Calls For Value Creation Instead Of Value Extraction In Pharmaceutical R&D 15/10/2018 David Branigan A new report, “The People's Prescription: Re-imagining health innovation to deliver public value,” calls for restructuring research and development innovation systems to create, rather than extract, value. It also calls for long-term “mission-oriented” public investment, and a public return on this investment. Continue reading -> Investing In Tobacco Free Portfolios: An Interview With Bronwyn King 11/10/2018 William New BAD GASTEIN, Austria -- People and institutions around the world may be unknowingly contributing to “the world’s number one cause of preventable death, via their pension funds,” according to Tobacco Free Portfolios, a global group working to cut off investment in tobacco products. And policymakers have a role to play, says the group’s CEO, Bronwyn King. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Immunisation Programmes In Africa Face Challenges 19/10/2018 Justus Wanzala NAIROBI, Kenya -- Countries in sub-Saharan Africa face myriad obstacles in ensuring their populations receive requisite vaccinations to combat diseases. Continue reading -> Antimicrobial Resistance At The World Investment Forum: UNCTAD, WHO Join Forces 16/10/2018 Catherine Saez The World Investment Forum 2018, a biennial event organised by the United Nations Conference on Trade and Development (UNCTAD), will hold a session on health this year jointly with the World Health Organization. The session will address the need for investment in the development of new antibiotics, hoping to raise interest among investors. Continue reading -> World Health Summit: 11 Groups Sign Collaboration; Civil Society Sees Lack Of NGOs 16/10/2018 Monika Ermert BERLIN -- Answering the call by German Chancellor Angela Merkel, Ghana's President Nana Addo Dankwa Akufo-Addo and Norway's Prime Minister Erna Solberg for a global action plan for pushing global health, heads of 11 major health organisations today signed “a commitment to find new ways of working together to accelerate progress towards achieving the United Nations’ Sustainable Development Goals” at the close of the World Health Summit in Berlin. Continue reading -> An Expert View: After The UN High-Level Meetings On TB, NCDs, What Happens Next? 16/10/2018 David Branigan The United Nations late last month sought to hold landmark high-level meetings on ending tuberculosis and fighting noncommunicable diseases like cancer and cardiovascular disease, with mixed results. Now a Swiss-based expert is looking at the outcomes and what comes next, and in a webinar talked about the political trade-offs resulting from the meetings, the need to push for an integrated agenda on Universal Health Coverage, and how the private sector should be engaged. Continue reading -> Novartis, GARDP Join Forces To Reduce Child Deaths From Antimicrobial Resistance 16/10/2018 David Branigan Novartis and the Global Antibiotic Research & Development Partnership (GARDP) have announced that they are “joining forces” to reduce child deaths from antimicrobial resistance (AMR) by accelerating “the development and availability of generic antibiotic treatments for children in low- and middle-income countries,” according to a GARDP press release. Continue reading -> World Health Summit Berlin: New Global Action Plan; Gates And Merkel To Open Global Challenges 15/10/2018 Monika Ermert BERLIN -- Ten years after establishing the Berlin World Health Summit, the M8 alliance of medical institutes around the globe sees some noticeable progress in political commitment to the health agenda. “Gifts” presented at the opening ceremony yesterday in the German capital include the announcement of German Health Minister Jens Spahn to establish a Hub for Global Health and step up its financial contributions to the World Health Organization (WHO) to 115 million euros over the next four years. The three-day summit also will receive a global action plan to catch up with the United Nations Sustainable Development Goal (SDG) 3 on health and well-being for all. Continue reading -> “The People’s Prescription”: New Report Calls For Value Creation Instead Of Value Extraction In Pharmaceutical R&D 15/10/2018 David Branigan A new report, “The People's Prescription: Re-imagining health innovation to deliver public value,” calls for restructuring research and development innovation systems to create, rather than extract, value. It also calls for long-term “mission-oriented” public investment, and a public return on this investment. Continue reading -> Investing In Tobacco Free Portfolios: An Interview With Bronwyn King 11/10/2018 William New BAD GASTEIN, Austria -- People and institutions around the world may be unknowingly contributing to “the world’s number one cause of preventable death, via their pension funds,” according to Tobacco Free Portfolios, a global group working to cut off investment in tobacco products. And policymakers have a role to play, says the group’s CEO, Bronwyn King. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Antimicrobial Resistance At The World Investment Forum: UNCTAD, WHO Join Forces 16/10/2018 Catherine Saez The World Investment Forum 2018, a biennial event organised by the United Nations Conference on Trade and Development (UNCTAD), will hold a session on health this year jointly with the World Health Organization. The session will address the need for investment in the development of new antibiotics, hoping to raise interest among investors. Continue reading -> World Health Summit: 11 Groups Sign Collaboration; Civil Society Sees Lack Of NGOs 16/10/2018 Monika Ermert BERLIN -- Answering the call by German Chancellor Angela Merkel, Ghana's President Nana Addo Dankwa Akufo-Addo and Norway's Prime Minister Erna Solberg for a global action plan for pushing global health, heads of 11 major health organisations today signed “a commitment to find new ways of working together to accelerate progress towards achieving the United Nations’ Sustainable Development Goals” at the close of the World Health Summit in Berlin. Continue reading -> An Expert View: After The UN High-Level Meetings On TB, NCDs, What Happens Next? 16/10/2018 David Branigan The United Nations late last month sought to hold landmark high-level meetings on ending tuberculosis and fighting noncommunicable diseases like cancer and cardiovascular disease, with mixed results. Now a Swiss-based expert is looking at the outcomes and what comes next, and in a webinar talked about the political trade-offs resulting from the meetings, the need to push for an integrated agenda on Universal Health Coverage, and how the private sector should be engaged. Continue reading -> Novartis, GARDP Join Forces To Reduce Child Deaths From Antimicrobial Resistance 16/10/2018 David Branigan Novartis and the Global Antibiotic Research & Development Partnership (GARDP) have announced that they are “joining forces” to reduce child deaths from antimicrobial resistance (AMR) by accelerating “the development and availability of generic antibiotic treatments for children in low- and middle-income countries,” according to a GARDP press release. Continue reading -> World Health Summit Berlin: New Global Action Plan; Gates And Merkel To Open Global Challenges 15/10/2018 Monika Ermert BERLIN -- Ten years after establishing the Berlin World Health Summit, the M8 alliance of medical institutes around the globe sees some noticeable progress in political commitment to the health agenda. “Gifts” presented at the opening ceremony yesterday in the German capital include the announcement of German Health Minister Jens Spahn to establish a Hub for Global Health and step up its financial contributions to the World Health Organization (WHO) to 115 million euros over the next four years. The three-day summit also will receive a global action plan to catch up with the United Nations Sustainable Development Goal (SDG) 3 on health and well-being for all. Continue reading -> “The People’s Prescription”: New Report Calls For Value Creation Instead Of Value Extraction In Pharmaceutical R&D 15/10/2018 David Branigan A new report, “The People's Prescription: Re-imagining health innovation to deliver public value,” calls for restructuring research and development innovation systems to create, rather than extract, value. It also calls for long-term “mission-oriented” public investment, and a public return on this investment. Continue reading -> Investing In Tobacco Free Portfolios: An Interview With Bronwyn King 11/10/2018 William New BAD GASTEIN, Austria -- People and institutions around the world may be unknowingly contributing to “the world’s number one cause of preventable death, via their pension funds,” according to Tobacco Free Portfolios, a global group working to cut off investment in tobacco products. And policymakers have a role to play, says the group’s CEO, Bronwyn King. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
World Health Summit: 11 Groups Sign Collaboration; Civil Society Sees Lack Of NGOs 16/10/2018 Monika Ermert BERLIN -- Answering the call by German Chancellor Angela Merkel, Ghana's President Nana Addo Dankwa Akufo-Addo and Norway's Prime Minister Erna Solberg for a global action plan for pushing global health, heads of 11 major health organisations today signed “a commitment to find new ways of working together to accelerate progress towards achieving the United Nations’ Sustainable Development Goals” at the close of the World Health Summit in Berlin. Continue reading -> An Expert View: After The UN High-Level Meetings On TB, NCDs, What Happens Next? 16/10/2018 David Branigan The United Nations late last month sought to hold landmark high-level meetings on ending tuberculosis and fighting noncommunicable diseases like cancer and cardiovascular disease, with mixed results. Now a Swiss-based expert is looking at the outcomes and what comes next, and in a webinar talked about the political trade-offs resulting from the meetings, the need to push for an integrated agenda on Universal Health Coverage, and how the private sector should be engaged. Continue reading -> Novartis, GARDP Join Forces To Reduce Child Deaths From Antimicrobial Resistance 16/10/2018 David Branigan Novartis and the Global Antibiotic Research & Development Partnership (GARDP) have announced that they are “joining forces” to reduce child deaths from antimicrobial resistance (AMR) by accelerating “the development and availability of generic antibiotic treatments for children in low- and middle-income countries,” according to a GARDP press release. Continue reading -> World Health Summit Berlin: New Global Action Plan; Gates And Merkel To Open Global Challenges 15/10/2018 Monika Ermert BERLIN -- Ten years after establishing the Berlin World Health Summit, the M8 alliance of medical institutes around the globe sees some noticeable progress in political commitment to the health agenda. “Gifts” presented at the opening ceremony yesterday in the German capital include the announcement of German Health Minister Jens Spahn to establish a Hub for Global Health and step up its financial contributions to the World Health Organization (WHO) to 115 million euros over the next four years. The three-day summit also will receive a global action plan to catch up with the United Nations Sustainable Development Goal (SDG) 3 on health and well-being for all. Continue reading -> “The People’s Prescription”: New Report Calls For Value Creation Instead Of Value Extraction In Pharmaceutical R&D 15/10/2018 David Branigan A new report, “The People's Prescription: Re-imagining health innovation to deliver public value,” calls for restructuring research and development innovation systems to create, rather than extract, value. It also calls for long-term “mission-oriented” public investment, and a public return on this investment. Continue reading -> Investing In Tobacco Free Portfolios: An Interview With Bronwyn King 11/10/2018 William New BAD GASTEIN, Austria -- People and institutions around the world may be unknowingly contributing to “the world’s number one cause of preventable death, via their pension funds,” according to Tobacco Free Portfolios, a global group working to cut off investment in tobacco products. And policymakers have a role to play, says the group’s CEO, Bronwyn King. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
An Expert View: After The UN High-Level Meetings On TB, NCDs, What Happens Next? 16/10/2018 David Branigan The United Nations late last month sought to hold landmark high-level meetings on ending tuberculosis and fighting noncommunicable diseases like cancer and cardiovascular disease, with mixed results. Now a Swiss-based expert is looking at the outcomes and what comes next, and in a webinar talked about the political trade-offs resulting from the meetings, the need to push for an integrated agenda on Universal Health Coverage, and how the private sector should be engaged. Continue reading -> Novartis, GARDP Join Forces To Reduce Child Deaths From Antimicrobial Resistance 16/10/2018 David Branigan Novartis and the Global Antibiotic Research & Development Partnership (GARDP) have announced that they are “joining forces” to reduce child deaths from antimicrobial resistance (AMR) by accelerating “the development and availability of generic antibiotic treatments for children in low- and middle-income countries,” according to a GARDP press release. Continue reading -> World Health Summit Berlin: New Global Action Plan; Gates And Merkel To Open Global Challenges 15/10/2018 Monika Ermert BERLIN -- Ten years after establishing the Berlin World Health Summit, the M8 alliance of medical institutes around the globe sees some noticeable progress in political commitment to the health agenda. “Gifts” presented at the opening ceremony yesterday in the German capital include the announcement of German Health Minister Jens Spahn to establish a Hub for Global Health and step up its financial contributions to the World Health Organization (WHO) to 115 million euros over the next four years. The three-day summit also will receive a global action plan to catch up with the United Nations Sustainable Development Goal (SDG) 3 on health and well-being for all. Continue reading -> “The People’s Prescription”: New Report Calls For Value Creation Instead Of Value Extraction In Pharmaceutical R&D 15/10/2018 David Branigan A new report, “The People's Prescription: Re-imagining health innovation to deliver public value,” calls for restructuring research and development innovation systems to create, rather than extract, value. It also calls for long-term “mission-oriented” public investment, and a public return on this investment. Continue reading -> Investing In Tobacco Free Portfolios: An Interview With Bronwyn King 11/10/2018 William New BAD GASTEIN, Austria -- People and institutions around the world may be unknowingly contributing to “the world’s number one cause of preventable death, via their pension funds,” according to Tobacco Free Portfolios, a global group working to cut off investment in tobacco products. And policymakers have a role to play, says the group’s CEO, Bronwyn King. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Novartis, GARDP Join Forces To Reduce Child Deaths From Antimicrobial Resistance 16/10/2018 David Branigan Novartis and the Global Antibiotic Research & Development Partnership (GARDP) have announced that they are “joining forces” to reduce child deaths from antimicrobial resistance (AMR) by accelerating “the development and availability of generic antibiotic treatments for children in low- and middle-income countries,” according to a GARDP press release. Continue reading -> World Health Summit Berlin: New Global Action Plan; Gates And Merkel To Open Global Challenges 15/10/2018 Monika Ermert BERLIN -- Ten years after establishing the Berlin World Health Summit, the M8 alliance of medical institutes around the globe sees some noticeable progress in political commitment to the health agenda. “Gifts” presented at the opening ceremony yesterday in the German capital include the announcement of German Health Minister Jens Spahn to establish a Hub for Global Health and step up its financial contributions to the World Health Organization (WHO) to 115 million euros over the next four years. The three-day summit also will receive a global action plan to catch up with the United Nations Sustainable Development Goal (SDG) 3 on health and well-being for all. Continue reading -> “The People’s Prescription”: New Report Calls For Value Creation Instead Of Value Extraction In Pharmaceutical R&D 15/10/2018 David Branigan A new report, “The People's Prescription: Re-imagining health innovation to deliver public value,” calls for restructuring research and development innovation systems to create, rather than extract, value. It also calls for long-term “mission-oriented” public investment, and a public return on this investment. Continue reading -> Investing In Tobacco Free Portfolios: An Interview With Bronwyn King 11/10/2018 William New BAD GASTEIN, Austria -- People and institutions around the world may be unknowingly contributing to “the world’s number one cause of preventable death, via their pension funds,” according to Tobacco Free Portfolios, a global group working to cut off investment in tobacco products. And policymakers have a role to play, says the group’s CEO, Bronwyn King. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
World Health Summit Berlin: New Global Action Plan; Gates And Merkel To Open Global Challenges 15/10/2018 Monika Ermert BERLIN -- Ten years after establishing the Berlin World Health Summit, the M8 alliance of medical institutes around the globe sees some noticeable progress in political commitment to the health agenda. “Gifts” presented at the opening ceremony yesterday in the German capital include the announcement of German Health Minister Jens Spahn to establish a Hub for Global Health and step up its financial contributions to the World Health Organization (WHO) to 115 million euros over the next four years. The three-day summit also will receive a global action plan to catch up with the United Nations Sustainable Development Goal (SDG) 3 on health and well-being for all. Continue reading -> “The People’s Prescription”: New Report Calls For Value Creation Instead Of Value Extraction In Pharmaceutical R&D 15/10/2018 David Branigan A new report, “The People's Prescription: Re-imagining health innovation to deliver public value,” calls for restructuring research and development innovation systems to create, rather than extract, value. It also calls for long-term “mission-oriented” public investment, and a public return on this investment. Continue reading -> Investing In Tobacco Free Portfolios: An Interview With Bronwyn King 11/10/2018 William New BAD GASTEIN, Austria -- People and institutions around the world may be unknowingly contributing to “the world’s number one cause of preventable death, via their pension funds,” according to Tobacco Free Portfolios, a global group working to cut off investment in tobacco products. And policymakers have a role to play, says the group’s CEO, Bronwyn King. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
“The People’s Prescription”: New Report Calls For Value Creation Instead Of Value Extraction In Pharmaceutical R&D 15/10/2018 David Branigan A new report, “The People's Prescription: Re-imagining health innovation to deliver public value,” calls for restructuring research and development innovation systems to create, rather than extract, value. It also calls for long-term “mission-oriented” public investment, and a public return on this investment. Continue reading -> Investing In Tobacco Free Portfolios: An Interview With Bronwyn King 11/10/2018 William New BAD GASTEIN, Austria -- People and institutions around the world may be unknowingly contributing to “the world’s number one cause of preventable death, via their pension funds,” according to Tobacco Free Portfolios, a global group working to cut off investment in tobacco products. And policymakers have a role to play, says the group’s CEO, Bronwyn King. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Investing In Tobacco Free Portfolios: An Interview With Bronwyn King 11/10/2018 William New BAD GASTEIN, Austria -- People and institutions around the world may be unknowingly contributing to “the world’s number one cause of preventable death, via their pension funds,” according to Tobacco Free Portfolios, a global group working to cut off investment in tobacco products. And policymakers have a role to play, says the group’s CEO, Bronwyn King. Continue reading -> Posts navigation Older Posts Newer Posts